XML 83 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Income Taxes (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Line Items]      
Net change in the total valuation allowance $ 2,300    
Received amount of Chemomab Therapeutics Inc   $ 351  
Expects to receive amount of Chemomab Therapeutics Inc 183    
Income tax benefit $ 0 (534) $ 0
Israel [Member]      
Income Tax Disclosure [Line Items]      
Corporate tax rate 23.00%    
Capital losses carryforwards $ 165,000 $ 159,000 $ 143,000
U.S. [Member] | Federal [Member]      
Income Tax Disclosure [Line Items]      
Corporate tax rate 21.00%